1. Market Definition & Scope
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Declining Costs of Sequencing
4.2.2. Funding and Investments from Private & Public Organizations
4.2.3. Surge in Prevalence of Genetic Diseases
4.3. Restraints
4.3.1. Lack of Standardized Approaches in Genomics
4.3.2. Data Privacy Concerns Pertaining to Genomic Information
4.4. Opportunities
4.4.1. Rising Adoption of Personalized Medicines and Gene Therapy
4.5. Challenges
4.5.1. Shortage of Skilled Workforce in Bioinformatics and Genomics
4.5.2. Challenges Pertaining to the Commercialization and Scaling of Genomic Technologies
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Case Study
5. Global Genomics Market Assessment—by Offering
5.1. Overview
5.2. Systems
5.3. Consumables
5.4. Software & Services
6. Global Genomics Market Assessment—by Technology
6.1. Overview
6.2. Sequencing
6.2.1. NGS
6.2.2. Sanger Sequencing and Pyrosequencing
6.3. DNA Microarray
6.4. PCR
6.5. Nucleic Acid Extraction and Purification
6.6. Other Technologies
7. Global Genomics Market Assessment—by Application
7.1. Overview
7.2. Drug Discovery & Development
7.3. Diagnostics
7.4. Life Science Research
7.4.1. Stem Cell Research
7.4.2. Cancer Research
7.4.3. Other Life Science Research
7.5. Other Applications
8. Global Genomics Market Assessment—by End User
8.1. Overview
8.2. Pharmaceutical & Biotechnology Companies
8.3. Hospitals
8.4. Academic & Research Institutes
8.5. Diagnostic Laboratories
8.6. Contract Research Organizations (CROs)
8.7. Other End Users
9. Genomics Market Assessment—by Geography
9.1. Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe (RoE)
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Rest of Asia-Pacific (RoAPAC)
9.5. Latin America
9.5.1. Brazil
9.5.2. Mexico
9.5.3. Rest of Latin America (RoLATAM)
9.6. Middle East & Africa
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Dashboard
10.3.1. Industry Leaders
10.3.2. Market Differentiators
10.3.3. Vanguards
10.3.4. Emerging Companies
10.4. Vendor Market Positioning
10.5. Market Share Analysis (2022)
11. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, and Strategic Developments)
11.1. Agilent Technologies, Inc.
11.2. Pacific Biosciences of California, Inc.
11.3. Danaher Corporation
11.4. F. Hoffmann-La Roche Ltd
11.5. Bio-Rad Laboratories, Inc.
11.6. Thermo Fisher Scientific Inc.
11.7. Myriad Genetics, Inc.
11.8. Illumina, Inc.
11.9. Oxford Nanopore Technologies plc
11.10. New England Biolabs, Inc.
11.11. Promega Corporation
11.12. QIAGEN N.V.
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Global Genomics Market: Impact Analysis of Drivers (2023–2030)
Table 2 Global Genomics Market: Impact Analysis of Restraints (2023–2030)
Table 3 Global Genomics Market Opportunities: Impact Analysis of Opportunities (2023–2030)
Table 4 Global Genomics Market: Impact Analysis of Challenges (2023–2030)
Table 5 Global Genomics Market, by Offering, 2021–2030 (USD Million)
Table 6 Global Genomics Systems Market, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Genomics Consumables Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Genomics Software & Services Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Genomics Market, by Technology, 2021–2030 (USD Million)
Table 10 Global Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 11 Global Genomics Market for Sequencing, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Genomics Market for NGS, by Country/Region, 2021–2030 (USD Million)
Table 13 Global Genomics Market for Sanger Sequencing and Pyrosequencing, by Country/Region, 2021–2030 (USD Million)
Table 14 Global Genomics Market for DNA Microarray, by Country/Region, 2021–2030 (USD Million)
Table 15 Global Genomics Market for PCR, by Country/Region, 2021–2030 (USD Million)
Table 16 Global Genomics Market for Nucleic Acid Extraction and Purification, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Genomics Market for Other Technologies, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Genomics Market, by Application, 2021–2030 (USD Million)
Table 19 Global Genomics Market for Drug Discovery & Development, by Country/Region, 2021–2030 (USD Million)
Table 20 Global Genomics Market for Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 21 Global Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 22 Global Genomics Market for Life Research, by Country/Region, 2021–2030 (USD Million)
Table 23 Global Genomics Market for Stem Cell Research, by Country/Region, 2021–2030 (USD Million)
Table 24 Global Genomics Market for Cancer Research, by Country/Region, 2021–2030 (USD Million)
Table 25 Global Genomics Market for Other Life Science Research, by Country/Region, 2021–2030 (USD Million)
Table 26 Global Genomics Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 27 Global Genomics Market, by End User, 2021–2030 (USD Million)
Table 28 Global Genomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2021–2030 (USD Million)
Table 29 Global Genomics Market for Hospitals, by Country/Region, 2021–2030 (USD Million)
Table 30 Global Genomics Market for Academic & Research Institutes, by Country/Region, 2021–2030 (USD Million)
Table 31 Global Genomics Market for Diagnostic Laboratories, by Country/Region, 2021–2030 (USD Million)
Table 32 Global Genomics Market for Contract Research Organizations (CROs), by Country/Region, 2021–2030 (USD Million)
Table 33 Global Genomics Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 34 Global Genomics Market, by Country/Region, 2021–2030 (USD Million)
Table 35 North America: Genomics Market, by Country, 2021–2030 (USD Million)
Table 36 North America: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 37 North America: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 38 North America: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 39 North America: Genomics Market, by Application, 2021–2030 (USD Million)
Table 40 North America: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 41 North America: Genomics Market, by End User, 2021–2030 (USD Million)
Table 42 U.S.: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 43 U.S.: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 44 U.S.: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 45 U.S.: Genomics Market, by Application, 2021–2030 (USD Million)
Table 46 U.S.: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 47 U.S.: Genomics Market, by End User, 2021–2030 (USD Million)
Table 48 Canada: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 49 Canada: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 50 Canada: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 51 Canada: Genomics Market, by Application, 2021–2030 (USD Million)
Table 52 Canada: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 53 Canada: Genomics Market, by End User, 2021–2030 (USD Million)
Table 54 Europe: Genomics Market, by Country/Region, 2021–2030 (USD Million)
Table 55 Europe: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 56 Europe: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 57 Europe: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 58 Europe: Genomics Market, by Application, 2021–2030 (USD Million)
Table 59 Europe: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 60 Europe: Genomics Market, by End User, 2021–2030 (USD Million)
Table 61 Germany: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 62 Germany: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 63 Germany: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 64 Germany: Genomics Market, by Application, 2021–2030 (USD Million)
Table 65 Germany: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 66 Germany: Genomics Market, by End User, 2021–2030 (USD Million)
Table 67 U.K.: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 68 U.K.: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 69 U.K.: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 70 U.K.: Genomics Market, by Application, 2021–2030 (USD Million)
Table 71 U.K.: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 72 U.K.: Genomics Market, by End User, 2021–2030 (USD Million)
Table 73 France: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 74 France: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 75 France: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 76 France: Genomics Market, by Application, 2021–2030 (USD Million)
Table 77 France: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 78 France: Genomics Market, by End User, 2021–2030 (USD Million)
Table 79 Italy: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 80 Italy: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 81 Italy: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 82 Italy: Genomics Market, by Application, 2021–2030 (USD Million)
Table 83 Italy: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 84 Italy: Genomics Market, by End User, 2021–2030 (USD Million)
Table 85 Spain: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 86 Spain: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 87 Spain: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 88 Spain: Genomics Market, by Application, 2021–2030 (USD Million)
Table 89 Spain: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 90 Spain: Genomics Market, by End User, 2021–2030 (USD Million)
Table 91 Rest of Europe: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 92 Rest of Europe: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 93 Rest of Europe: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 94 Rest of Europe: Genomics Market, by Application, 2021–2030 (USD Million)
Table 95 Rest of Europe: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 96 Rest of Europe: Genomics Market, by End User, 2021–2030 (USD Million)
Table 97 Asia-Pacific: Genomics Market, by Country/Region, 2021–2030 (USD Million)
Table 98 Asia-Pacific: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 99 Asia-Pacific: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 100 Asia-Pacific: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 101 Asia-Pacific: Genomics Market, by Application, 2021–2030 (USD Million)
Table 102 Asia-Pacific: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 103 Asia-Pacific: Genomics Market, by End User, 2021–2030 (USD Million)
Table 104 Japan: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 105 Japan: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 106 Japan: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 107 Japan: Genomics Market, by Application, 2021–2030 (USD Million)
Table 108 Japan: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 109 Japan: Genomics Market, by End User, 2021–2030 (USD Million)
Table 110 China: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 111 China: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 112 China: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 113 China: Genomics Market, by Application, 2021–2030 (USD Million)
Table 114 China: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 115 China: Genomics Market, by End User, 2021–2030 (USD Million)
Table 116 India: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 117 India: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 118 India: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 119 India: Genomics Market, by Application, 2021–2030 (USD Million)
Table 120 India: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 121 India: Genomics Market, by End User, 2021–2030 (USD Million)
Table 122 Rest of Asia-Pacific: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 123 Rest of Asia-Pacific: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 124 Rest of Asia-Pacific: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 125 Rest of Asia-Pacific: Genomics Market, by Application, 2021–2030 (USD Million)
Table 126 Rest of Asia-Pacific: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 127 Rest of Asia-Pacific: Genomics Market, by End User, 2021–2030 (USD Million)
Table 128 Latin America: Genomics Market, by Country/Region, 2021–2030 (USD Million)
Table 129 Latin America: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 130 Latin America: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 131 Latin America: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 132 Latin America: Genomics Market, by Application, 2021–2030 (USD Million)
Table 133 Latin America: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 134 Latin America: Genomics Market, by End User, 2021–2030 (USD Million)
Table 135 Brazil: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 136 Brazil: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 137 Brazil: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 138 Brazil: Genomics Market, by Application, 2021–2030 (USD Million)
Table 139 Brazil: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 140 Brazil: Genomics Market, by End User, 2021–2030 (USD Million)
Table 141 Mexico: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 142 Mexico: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 143 Mexico: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 144 Mexico: Genomics Market, by Application, 2021–2030 (USD Million)
Table 145 Mexico: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 146 Mexico: Genomics Market, by End User, 2021–2030 (USD Million)
Table 147 Rest of Latin America: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 148 Rest of Latin America: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 149 Rest of Latin America: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 150 Rest of Latin America: Genomics Market, by Application, 2021–2030 (USD Million)
Table 151 Rest of Latin America: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 152 Rest of Latin America: Genomics Market, by End User, 2021–2030 (USD Million)
Table 153 Middle East & Africa: Genomics Market, by Offering, 2021–2030 (USD Million)
Table 154 Middle East & Africa: Genomics Market, by Technology, 2021–2030 (USD Million)
Table 155 Middle East & Africa: Genomics Market for Sequencing, by Type, 2021–2030 (USD Million)
Table 156 Middle East & Africa: Genomics Market, by Application, 2021–2030 (USD Million)
Table 157 Middle East & Africa: Genomics Market for Life Science Research, by Type, 2021–2030 (USD Million)
Table 158 Middle East & Africa: Genomics Market, by End User, 2021–2030 (USD Million)
Table 159 Recent Developments, by Company (2020–2023)
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Estimation
Figure 7 Global Genomics Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 8 Global Genomics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Global Genomics Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Global Genomics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 11 Global Genomics Market, by Geography
Figure 12 Market Dynamics
Figure 13 Global Genomics Market, by Offering, 2023 Vs. 2030 (USD Million)
Figure 14 Global Genomics Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 15 Global Genomics Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 16 Global Genomics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 17 Global Genomics Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 18 North America: Genomics Market Snapshot
Figure 19 Europe: Genomics Market Snapshot
Figure 20 Asia-Pacific: Genomics Market Snapshot
Figure 21 Latin America: Genomics Market Snapshot
Figure 22 Key Growth Strategies Adopted by Leading Players (2019–2023)
Figure 23 Genomics Market: Competitive Benchmarking, by Offering
Figure 24 Genomics Market: Competitive Benchmarking, by Technology
Figure 25 Competitive Dashboard: Genomics Market
Figure 26 Market Share Analysis: Genomics Market (2022)
Figure 27 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 28 Pacific Biosciences of California, Inc.: Financial Overview (2022)
Figure 29 Danaher Corporation: Financial Overview (2022)
Figure 30 F. Hoffmann-La Roche Ltd: Financial Overview (2022)
Figure 31 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 32 Thermo Fisher Scientific Inc.: Financial Overview (2022)
Figure 33 Myriad Genetics, Inc.: Financial Overview (2022)
Figure 34 Illumina, Inc.: Financial Overview (2022)
Figure 35 Oxford Nanopore Technologies plc: Financial Overview (2021)
Figure 36 QIAGEN N.V.: Financial Overview (2022)
COVID-19
This report provides pre & post COVID-19 market estimates.